Urinary NGF, TGF-β1, TIMP-2 and Bladder Wall Thickness Predict Neurourological Findings in Children with Myelodysplasia
Abstract
Purpose:
Dimercapto-succinic acid scintigraphy and urodynamic studies are gold standards to evaluate renal scarring and neurogenic bladder dysfunction, respectively. We sought to establish the value of bladder wall thickness together with urine NGF, TGF-β1 and TIMP-2 to predict the urodynamic profile and upper urinary tract damage in children with myelodysplasia.
Materials and Methods:
A total of 80 children with myelodysplasia underwent urodynamic investigation, bladder wall thickness measurement and dimercapto-succinic acid scintigraphy with basic neurourological evaluation. Two study and 2 control groups were created according to presence or absence of renal scarring on dimercapto-succinic acid scan (study and control groups 1) and according to detrusor leak point pressure greater or less than 40 cm H2O (study and control groups 2). Urine samples were analyzed with ELISA.
Results:
The study population consisted of 44 girls and 36 boys with a median ± SD age of 7.2 ± 3.6 years (range 2 to 17). Study and control groups 1 consisted of 35 and 45 children with abnormal and normal dimercapto-succinic acid scan findings, respectively. Study and control groups 2 included 30 and 50 children with detrusor leak point pressure greater and less than 40 cm H2O, respectively. Bladder wall thickness and urinary levels of TGF-β1, NGF and TIMP-2 were significantly increased in both study groups compared to controls.
Conclusions:
Urine markers and bladder wall thickness measurement may predict urinary tract impairment in children with myelodysplasia. Such markers may differentiate at risk patients with either renal scarring or high detrusor leak point pressure, and decrease the need for urodynamics and renal scintigraphy.
References
- 1 Kataria R, Bajpai M, Lall A et al: Neurogenic bladder: urodynamic and surgical aspects. Indian J Pediatr, suppl., 1997; 64: 68. Google Scholar
- 2 : Neurogenic bladder: etiology and assessment. Pediatr Nephrol2008; 23: 541. Google Scholar
- 3 : Renal parenchymal radiographic measurement in infants and children. Pediatr Radiol1975; 3: 16. Google Scholar
- 4 : Emergent pediatric US: what every radiologist should know. Radiographics2012; 32: 651. Google Scholar
- 5 : Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom. Int J Urol2005; 12: 875. Google Scholar
- 6 : Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model. J Urol2010; 183: 2440. Link, Google Scholar
- 7 : Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int2009; 104: 1476. Google Scholar
- 8 : Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int1995; 47: 1285. Google Scholar
- 9 : Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann N Y Acad Sci1999; 878: 388. Google Scholar
- 10 : Ultrasonographic measurement of bladder wall thickness as a risk factor for upper urinary tract deterioration in children with myelodysplasia. J Urol2008; 180: 312. Link, Google Scholar
- 11 : Ultrasound assessment of detrusor muscle thickness in children with non-neuropathic bladder/sphincter dysfunction. Eur Urol2002; 41: 214. Google Scholar
- 12 : Ultrasound assessment of detrusor thickness in children and young adults with myelomeningocele. J Urol2006; 175: 704. Link, Google Scholar
- 13 : Detrusor thickness in healthy children assessed by a standardized ultrasound method. J Urol2001; 166: 2364. Link, Google Scholar
- 14 : Role of nerve growth factor receptor on bladder outlet obstruction. Turk J Urol2004; 30: 72. Google Scholar
- 15 : Nerve growth factor synthesis in vascular smooth muscle. Hypertension1991; 18: 730. Google Scholar
- 16 : Regulation of nerve growth factor secretion in smooth muscle cells cultured from rat bladder body, base and urethra. J Urol1997; 157: 2000. Link, Google Scholar
- 17 : Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest1991; 88: 1709. Google Scholar
- 18 : Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol1997; 79: 572. Google Scholar
- 19 : Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Am J Physiol Regul Integr Comp Physiol2010; 298: R534. Google Scholar
- 20 : Urinary neurotrophic factors in healthy individuals and patients with overactive bladder. J Urol2013; 189: 359. Link, Google Scholar
- 21 : Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol2009; 56: 700. Google Scholar
- 22 : Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Urology2008; 72: 104. Google Scholar
- 23 : Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor. BJU Int2007; 99: 899. Google Scholar
- 24 : Transforming growth factor-beta1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up. Int Braz J Urol2009; 35: 315. Google Scholar
- 25 : Urinary transforming growth factor-beta1 in children with obstructive uropathy. Nephrology2011; 16: 595. Google Scholar
- 26 : Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res2003; 92: 827. Google Scholar
- 27 : Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J1991; 5: 2145. Google Scholar
